Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Bladder Cancer, November 2017

Free Subscription


Abstracts

Retrieve all available abstracts of the following 79 articles:
HTML format


 

Single Articles

  1. MAO XW, Xiao JQ, Xu G, Li ZY, et al
    CUL4B promotes bladder cancer metastasis and induces epithelial-to-mesenchymal transition by activating the Wnt/beta-catenin signaling pathway.
    Oncotarget. 2017;8:77241-77253.
    Abstract    

    Abstract available

  2. ZHAN Y, Li Y, Guan B, Wang Z, et al
    Long non-coding RNA HNF1A-AS1 promotes proliferation and suppresses apoptosis of bladder cancer cells through upregulating Bcl-2.
    Oncotarget. 2017;8:76656-76665.
    Abstract    

    Abstract available

  3. AL-AMER M, Abdeen Y, Shaaban H, Alderink C, et al
    Solitary pulmonary adenofibroma in a middle-aged man with bladder cancer.
    Lung India. 2017;34:570-572.
    Abstract    



  4. NIWA N, Kikuchi E, Matsumoto K, Kosaka T, et al
    Purified protein derivative skin test reactions are associated with clinical outcomes of patients with nonmuscle invasive bladder cancer treated with induction bacillus Calmette-Guerin therapy.
    Urol Oncol. 2017 Oct 30. pii: S1078-1439(17)30535.
    Abstract    

    Abstract available

  5. DEGEORGE KC, Holt HR, Hodges SC
    Bladder Cancer: Diagnosis and Treatment.
    Am Fam Physician. 2017;96:507-514.
    Abstract    

    Abstract available

  6. WALSHAW RC, Honeychurch J, Illidge TM, Choudhury A, et al
    The anti-PD-1 era - an opportunity to enhance radiotherapy for patients with bladder cancer.
    Nat Rev Urol. 2017 Oct 31. doi: 10.1038/nrurol.2017.
    Abstract    

    Abstract available

  7. GORDON PC, Thomas F, Noon AP, Rosario DJ, et al
    Long-term Outcomes from Re-resection for High-risk Non-muscle-invasive Bladder Cancer: A Potential to Rationalize Use.
    Eur Urol Focus. 2017 Oct 28. pii: S2405-4569(17)30241.
    Abstract    

    Abstract available

  8. LIU J, Gong X, Zhu X, Xue D, et al
    Rab27A overexpression promotes bladder cancer proliferation and chemoresistance through regulation of NF-kappaB signaling.
    Oncotarget. 2017;8:75272-75283.
    Abstract    

    Abstract available

  9. SATO M, Yoneyama MS, Hatakeyama S, Funyu T, et al
    The role of LIM and SH3 protein-1 in bladder cancer metastasis.
    Oncol Lett. 2017;14:4829-4834.
    Abstract    

    Abstract available

  10. ZHUANG C, Huang X, Zhuang C, Luo X, et al
    Synthetic regulatory RNAs selectively suppress the progression of bladder cancer.
    J Exp Clin Cancer Res. 2017;36:151.
    Abstract    

    Abstract available

  11. TAN DQ, Liu XH
    [Mechanism in growth inhibition of quercetin on human bladder cancer cell line].
    Zhongguo Zhong Yao Za Zhi. 2017;42:1742-1746.
    Abstract    

    Abstract available

  12. MITRAKAS L, Gravas S, Papandreou C, Koukoulis G, et al
    Primary High-Grade Non-Muscle-Invasive Bladder Cancer: High NFkappaB Expression in Tumor Specimens Distinguishes Patients Who are at Risk for Disease Progression.
    Pathol Oncol Res. 2017 Oct 28. doi: 10.1007/s12253-017-0340.
    Abstract    

    Abstract available

  13. LIN T, Li K, Liu H, Xue X, et al
    Enhanced recovery after surgery for radical cystectomy with ileal urinary diversion: a multi-institutional, randomized, controlled trial from the Chinese bladder cancer consortium.
    World J Urol. 2017 Oct 28. doi: 10.1007/s00345-017-2108.
    Abstract    

    Abstract available

  14. HENRY CJ, Flesner BK, Bechtel SA, Bryan JN, et al
    Clinical Evaluation of Tavocept to Decrease Diuresis Time and Volume in Dogs with Bladder Cancer Receiving Cisplatin.
    J Vet Intern Med. 2017 Oct 27. doi: 10.1111/jvim.14848.
    Abstract    

    Abstract available

  15. CHOUDHARY D, Clement JM, Choudhary S, Voznesensky O, et al
    SATB1 and bladder cancer: Is there a functional link?
    Urol Oncol. 2017 Oct 24. pii: S1078-1439(17)30531.
    Abstract    

    Abstract available

  16. LYNCH HN, Zu K, Kennedy EM, Lam T, et al
    Corrigendum to "Quantitative assessment of lung and bladder cancer risk and oral exposure to inorganic arsenic: Meta-regression analyses of epidemiological data" Environmental International 106 :178-206.
    Environ Int. 2017;109:195-196.
    Abstract    



  17. LEIVO MZ, Sahoo D, Hamilton Z, Mirsadraei L, et al
    Analysis of T1 Bladder Cancer on Biopsy and Transurethral Resection Specimens: Comparison and Ranking of T1 Quantification Approaches to Predict Progression to Muscularis Propria Invasion.
    Am J Surg Pathol. 2017 Oct 26. doi: 10.1097/PAS.0000000000000964.
    Abstract    

    Abstract available

  18. LIN YC, Lin JF, Tsai TF, Chen HE, et al
    Acridine orange exhibits photodamage in human bladder cancer cells under blue light exposure.
    Sci Rep. 2017;7:14103.
    Abstract    

    Abstract available

  19. HENDRICKSEN K, Aziz A, Bes P, Chun FK, et al
    Discrepancy Between European Association of Urology Guidelines and Daily Practice in the Management of Non-muscle-invasive Bladder Cancer: Results of a European Survey.
    Eur Urol Focus. 2017 Oct 23. pii: S2405-4569(17)30206.
    Abstract    

    Abstract available

  20. LI QQ, Hsu I, Sanford T, Railkar R, et al
    Protein kinase D inhibitor CRT0066101 suppresses bladder cancer growth in vitro and xenografts via blockade of the cell cycle at G2/M.
    Cell Mol Life Sci. 2017 Oct 25. doi: 10.1007/s00018-017-2681.
    Abstract    

    Abstract available

  21. ZAHRAN MH, Sheir K, Zidan EM, Ali-El-Dein B, et al
    Validation of the Arabic version of the Functional Assessment of Cancer Therapy-Bladder questionnaire in Egyptian patients with bladder cancer.
    Arab J Urol. 2017;15:110-114.
    Abstract    

    Abstract available

  22. AHN KI, Choi EO, Kwon DH, HwangBo H, et al
    Induction of apoptosis by ethanol extract of Citrus unshiu Markovich peel in human bladder cancer T24 cells through ROS-mediated inactivation of the PI3K/Akt pathway.
    Biosci Trends. 2017 Oct 24. doi: 10.5582/bst.2017.01218.
    Abstract    

    Abstract available

  23. TAO T, He C, Deng J, Huang Y, et al
    A novel synthetic derivative of quercetin, 8-trifluoromethyl-3,5,7,3',4'-O-pentamethyl-quercetin, inhibits bladder cancer growth by targeting the AMPK/mTOR signaling pathway.
    Oncotarget. 2017;8:71657-71671.
    Abstract    

    Abstract available

  24. YIN H, Yang X, Gu W, Liu Y, et al
    HMGB1-mediated autophagy attenuates gemcitabine-induced apoptosis in bladder cancer cells involving JNK and ERK activation.
    Oncotarget. 2017;8:71642-71656.
    Abstract    

    Abstract available

  25. ROBERTS KJ, Kershner AM, Beachy PA
    The Stromal Niche for Epithelial Stem Cells: A Template for Regeneration and a Brake on Malignancy.
    Cancer Cell. 2017;32:404-410.
    Abstract    

    Abstract available

  26. HATA S, Ise K, Azmahani A, Konosu-Fukaya S, et al
    Expression of AR, 5alphaR1 and 5alphaR2 in bladder urothelial carcinoma and relationship to clinicopathological factors.
    Life Sci. 2017;190:15-20.
    Abstract    

    Abstract available

  27. PINK M, Verma N, Zerries A, Schmitz-Spanke S, et al
    Dose-Dependent Response to 3-Nitrobenzanthrone Exposure in Human Urothelial Cancer Cells.
    Chem Res Toxicol. 2017;30:1855-1864.
    Abstract    

    Abstract available

  28. HODGKINSON L
    American Urological Association (AUA) - 112th Annual Meeting (May 12-16, 2017 - Boston, Massachusetts, USA).
    Drugs Today (Barc). 2017;53:367-369.
    Abstract    

    Abstract available

  29. JIKUYA R, Washimi K, Yasui M, Hashizume A, et al
    [A Case of Long Survival in Aggressively Growing Small Cell Carcinoma of the Bladder Successfully Treated by Combined Chemotherapy of Methotrexate, Etoposide and Cisplatin].
    Hinyokika Kiyo. 2017;63:245-249.
    Abstract    

    Abstract available

  30. STEENLAND K, Barry V, Anttila A, Sallmen M, et al
    A cohort mortality study of lead-exposed workers in the USA, Finland and the UK.
    Occup Environ Med. 2017;74:785-791.
    Abstract    

    Abstract available

  31. YAMADA M, Kuroda H, Sato K, Miura S, et al
    Spontaneous regression of methotrexate-related diffuse large B-cell lymphoma following bladder lesion resection.
    Rinsho Ketsueki. 2017;58:287-291.
    Abstract    

    Abstract available

  32. HUHE M, Liu S, Zhang Y, Zhang Z, et al
    Expression levels of transcription factors c-Fos and c-Jun and transmembrane protein HAb18G/CD147 in urothelial carcinoma of the bladder.
    Mol Med Rep. 2017;15:2991-3000.
    Abstract    

    Abstract available

  33. BUTT E, Ebbing J, Bubendorf L, Ardelt P, et al
    Influence of hematuria and infection on diagnostic accuracy of urinary LASP1: a new biomarker for bladder carcinoma.
    Biomark Med. 2017;11:347-357.
    Abstract    

    Abstract available

  34. ALANEE SR, Shah S, Zabor EC, Vijai J, et al
    Evaluating the association of multiple single nucleotide polymorphisms with response to gemcitabine and platinum combination chemotherapy in urothelial carcinoma of the bladder.
    Int J Clin Pharmacol Ther. 2017;55:203-209.
    Abstract    

    Abstract available

  35. MAUGERI R, Graziano F, Basile L, Guli C, et al
    Reconstruction of Vertebral Body After Radiofrequency Ablation and Augmentation in Dorsolumbar Metastatic Vertebral Fracture: Analysis of Clinical and Radiological Outcome in a Clinical Series of 18 Patients.
    Acta Neurochir Suppl. 2017;124:81-86.
    Abstract    

    Abstract available

  36. KRAJEWSKI W, Koscielska-Kasprzak K, Rymaszewska J, Zdrojowy R, et al
    How different cystoscopy methods influence patient sexual satisfaction, anxiety, and depression levels: a randomized prospective trial.
    Qual Life Res. 2017;26:625-634.
    Abstract    

    Abstract available

  37. XU ZQ, Yang MG, Liu HJ, Su CQ, et al
    Circular RNA hsa_circ_0003221 (circPTK2) promotes the proliferation and migration of bladder cancer cells.
    J Cell Biochem. 2017 Nov 10. doi: 10.1002/jcb.26492.
    Abstract    

    Abstract available

  38. PAQUETTE M, Vilera-Perez LG, Beaudoin S, Ekindi-Ndongo N, et al
    Targeting IL-5Ralpha with antibody-conjugates reveals a strategy for imaging and therapy for invasive bladder cancer.
    Oncoimmunology. 2017;6:e1331195.
    Abstract    

    Abstract available

  39. CASADEVALL D, Kilian AY, Bellmunt J
    The prognostic role of epigenetic dysregulation in bladder cancer: A systematic review.
    Cancer Treat Rev. 2017;61:82-93.
    Abstract    

    Abstract available

  40. SHEGAY PV, Zhavoronkov AA, Gaifullin NM, Vorob'ev NV, et al
    Potentialities of MicroRNA Diagnosis in Patients with Bladder Cancer.
    Bull Exp Biol Med. 2017 Nov 9. doi: 10.1007/s10517-017-3935.
    Abstract    

    Abstract available

  41. KOCHAN A, Rivest R, Galloway K, Lambert P, et al
    Targeting the Tumor: Assessing the Impact of Bladder Volume and Position on Accuracy of Radiation Delivery for Patients with Bladder Cancer.
    Cureus. 2017;9:e1638.
    Abstract    

    Abstract available

  42. RUTHERFORD C, King MT, Smith DP, Costa DS, et al
    Psychometric Evaluation of a Patient-Reported Symptom Index for Nonmuscle Invasive Bladder Cancer: Field Testing Protocol.
    JMIR Res Protoc. 2017;6:e216.
    Abstract    

    Abstract available

  43. BERDIK C
    Unlocking bladder cancer.
    Nature. 2017;551:S34-S35.
    Abstract    



  44. BERDIK C
    Bladder cancer: 4 big questions.
    Nature. 2017;551:S51.
    Abstract    



  45. GRAYSON M
    Bladder cancer.
    Nature. 2017;551:S33.
    Abstract    



  46. ZHANG J, Zhu Y, Wang Y, Fu Q, et al
    Prognostic and Predictive Value of O6-methylguanine Methyltransferase for Chemotherapy in Patients with Muscle-Invasive Bladder Cancer.
    Ann Surg Oncol. 2017 Nov 7. doi: 10.1245/s10434-017-6145.
    Abstract    

    Abstract available

  47. LI Q, Tang T, Zhang P, Liu C, et al
    Correlation of IL-31 gene polymorphisms with susceptibility and clinical recurrence of bladder cancer.
    Fam Cancer. 2017 Nov 8. doi: 10.1007/s10689-017-0060.
    Abstract    

    Abstract available

  48. FREES SK, Aning J, Black P, Struss W, et al
    A prospective randomized pilot study evaluating an ERAS protocol versus a standard protocol for patients treated with radical cystectomy and urinary diversion for bladder cancer.
    World J Urol. 2017 Nov 7. doi: 10.1007/s00345-017-2109.
    Abstract    

    Abstract available

  49. SATO T, Katsuoka Y, Yoneda K, Nonomura M, et al
    Sniffer mice discriminate urine odours of patients with bladder cancer: A proof-of-principle study for non-invasive diagnosis of cancer-induced odours.
    Sci Rep. 2017;7:14628.
    Abstract    

    Abstract available

  50. DEININGER S, Todenhofer T, Hennenlotter J, Gerber V, et al
    Impact of variant microscopic interpretation of the uCyt+ immunocytological urine test for the detection of bladder cancer.
    Diagn Cytopathol. 2017 Nov 8. doi: 10.1002/dc.23857.
    Abstract    

    Abstract available

  51. POUPEL F, Aghaei M, Movahedian A, Jafari SM, et al
    Dihydroartemisinin Induces Apoptosis in Human Bladder Cancer Cell Lines Through Reactive Oxygen Species, Mitochondrial Membrane Potential, and Cytochrome C Pathway.
    Int J Prev Med. 2017;8:78.
    Abstract    

    Abstract available

  52. KIM HS, Jeong CW, Kwak C, Kim HH, et al
    Adjuvant chemotherapy for muscle-invasive bladder cancer: a systematic review and network meta-analysis of randomized clinical trials.
    Oncotarget. 2017;8:81204-81214.
    Abstract    

    Abstract available

  53. ZHANG C, Wang YQ, Jin G, Wu S, et al
    Selection of reference genes for gene expression studies in human bladder cancer using SYBR-Green quantitative polymerase chain reaction.
    Oncol Lett. 2017;14:6001-6011.
    Abstract    

    Abstract available

  54. LUO J, Chen J, Li H, Yang Y, et al
    LncRNA UCA1 promotes the invasion and EMT of bladder cancer cells by regulating the miR-143/HMGB1 pathway.
    Oncol Lett. 2017;14:5556-5562.
    Abstract    

    Abstract available

  55. CHEN Y, Wang H, Xiong T, Zou R, et al
    The role of LASS2 in regulating bladder cancer cell tumorigenicity in a nude mouse model.
    Oncol Lett. 2017;14:5149-5156.
    Abstract    

    Abstract available

  56. ICHIKAWA H, Itsumi M, Kajioka S, Maki T, et al
    Overexpression of exchange protein directly activated by cAMP-1 (EPAC1) attenuates bladder cancer cell migration.
    Biochem Biophys Res Commun. 2017 Oct 27. pii: S0006-291X(17)32127.
    Abstract    

    Abstract available

  57. AEISHEN S, Dawood Y, Papadoukakis S, Horstmann M, et al
    [Supplementary optical techniques for the detection of nonmuscle invasive bladder cancer].
    Urologe A. 2017 Nov 6. doi: 10.1007/s00120-017-0539.
    Abstract    

    Abstract available

  58. LEBENTRAU S, May M, Wick AK, Roiner M, et al
    Non-muscle invasive bladder cancer: Are epicrises the 'Bermuda Triangle' of information transfer?
    Cent European J Urol. 2017;70:245-251.
    Abstract    

    Abstract available

  59. FAHMY O, Khairul-Asri MG, Schubert T, Renninger M, et al
    A systematic review and meta-analysis on the oncological long-term outcomes after trimodality therapy and radical cystectomy with or without neoadjuvant chemotherapy for muscle-invasive bladder cancer.
    Urol Oncol. 2017 Oct 25. pii: S1078-1439(17)30529.
    Abstract    

    Abstract available

  60. LIM-REINDERS S, Keller BM, Al-Ward S, Sahgal A, et al
    Online Adaptive Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2017;99:994-1003.
    Abstract    

    Abstract available

  61. NEUZILLET Y, Raynaud JP, Radulescu C, Fiet J, et al
    Sexual steroids in serum and prostatic tissue of human non-cancerous prostate (STERPROSER trial).
    Prostate. 2017;77:1512-1519.
    Abstract    

    Abstract available

  62. KOK HP, Korshuize-van Straten L, Bakker A, de Kroon-Oldenhof R, et al
    Online Adaptive Hyperthermia Treatment Planning During Locoregional Heating to Suppress Treatment-Limiting Hot Spots.
    Int J Radiat Oncol Biol Phys. 2017;99:1039-1047.
    Abstract    

    Abstract available

  63. GLYBOCHKO PV, Alyaev YG, Shpot' EV, Pshi-Khachev AM, et al
    [Laparoscopic cystoprostatvesiculeectomy with orthotopic excentric ileal bladder substitution].
    Urologiia. 2017;:78-83.
    Abstract    

    Abstract available

  64. ROBSAHM TE, Falk RS, Heir T, Sandvik L, et al
    Cardiorespiratory fitness and risk of site-specific cancers: a long-term prospective cohort study.
    Cancer Med. 2017;6:865-873.
    Abstract    

    Abstract available

  65. RAMOS JD, Casey MF, Crabb SJ, Bamias A, et al
    Venous thromboembolism in metastatic urothelial carcinoma or variant histologies: incidence, associative factors, and effect on survival.
    Cancer Med. 2017;6:186-194.
    Abstract    

    Abstract available

  66. LIAW CC, Chuang CK, Chang YH, Liao TY, et al
    Bladder Urothelial Carcinoma with Peritoneal Involvement: Benefit of Continuous Maintenance Chemotherapy.
    Anticancer Res. 2017;37:6443-6451.
    Abstract    

    Abstract available

  67. HSU FT, Sun CC, Wu CH, Lee YJ, et al
    Regorafenib Induces Apoptosis and Inhibits Metastatic Potential of Human Bladder Carcinoma Cells.
    Anticancer Res. 2017;37:4919-4926.
    Abstract    

    Abstract available

  68. KINNEAR N, Smith R, Hennessey DB, Bolton D, et al
    Implementation rates of uro-oncology multidisciplinary meeting decisions.
    BJU Int. 2017;120 Suppl 3:15-20.
    Abstract    

    Abstract available

  69. KASHIWAGI E, Inoue S, Mizushima T, Chen J, et al
    Prostaglandin receptors induce urothelial tumourigenesis as well as bladder cancer progression and cisplatin resistance presumably via modulating PTEN expression.
    Br J Cancer. 2017 Nov 9. doi: 10.1038/bjc.2017.
    Abstract    

    Abstract available

  70. DUEX JE, Owens C, Chauca-Diaz A, Dancik GM, et al
    Nuclear CD24 Drives Tumor Growth and Is Predictive of Poor Patient Prognosis.
    Cancer Res. 2017;77:4858-4867.
    Abstract    

    Abstract available

  71. MAIA MC, Grivas P, Agarwal N, Pal SK, et al
    Circulating Tumor DNA in Bladder Cancer: Novel Applications and Future Directions.
    Eur Urol. 2017 Oct 30. pii: S0302-2838(17)30902.
    Abstract    



  72. ABUFARAJ M, Dalbagni G, Daneshmand S, Horenblas S, et al
    The Role of Surgery in Metastatic Bladder Cancer: A Systematic Review.
    Eur Urol. 2017 Nov 6. pii: S0302-2838(17)30840.
    Abstract    

    Abstract available

  73. KIM CJ, Terado T, Tambe Y, Mukaisho KI, et al
    Anti-oncogenic activities of cyclin D1b siRNA on human bladder cancer cells via induction of apoptosis and suppression of cancer cell stemness and invasiveness.
    Int J Oncol. 2017 Nov 7. doi: 10.3892/ijo.2017.4194.
    Abstract    

    Abstract available

  74. LV XY, Ma L, Chen JF, Yu R, et al
    Knockdown of DUXAP10 inhibits proliferation and promotes apoptosis in bladder cancer cells via PI3K/Akt/mTOR signaling pathway.
    Int J Oncol. 2017 Nov 7. doi: 10.3892/ijo.2017.4195.
    Abstract    

    Abstract available

  75. TAN YG, Eu EWC, Huang HH, Lau WKO, et al
    High neutrophil-to-lymphocyte ratio predicts worse overall survival in patients with advanced/metastatic urothelial bladder cancer.
    Int J Urol. 2017 Nov 1. doi: 10.1111/iju.13480.
    Abstract    

    Abstract available

  76. YANG X, Shi L, Yi C, Yang Y, et al
    Astrocyte elevated gene-1 promotes invasion and epithelial-mesenchymal transition in bladder cancer cells through activation of signal transducer and activator of transcription 3.
    Int J Urol. 2017 Nov 8. doi: 10.1111/iju.13486.
    Abstract    

    Abstract available

  77. LONG X, Qi L, Zu X, Li Y, et al
    Prevention of Recurrent Bladder Tumors after Nephroureterectomy for Primary Upper Urinary Tract Urothelial Carcinoma: An Individualized Selection Strategy Based on Patient Risk Stratification Is Needed.
    Urol Int. 2017;98:312-319.
    Abstract    

    Abstract available

  78. WOLTERS M, Oelke M, Lutze B, Weingart M, et al
    Deep Surgical Site Infections after Open Radical Cystectomy and Urinary Diversion Significantly Increase Hospitalisation Time and Total Treatment Costs.
    Urol Int. 2017;98:268-273.
    Abstract    

    Abstract available

  79. MIYAKE M, Morizawa Y, Hori S, Marugami N, et al
    Clinical impact of postoperative loss in psoas major muscle and nutrition index after radical cystectomy for patients with urothelial carcinoma of the bladder.
    BMC Cancer. 2017;17:237.
    Abstract    

    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;